Gyre Therapeutics posts updated corporate presentation; no new material facts disclosed

GYRE THERAPEUTICS, INC.

Company posted updated corporate presentation dated September 2026 on its website on September 1, 2026.
Presentation furnished as Exhibit 99.1; exhibit body text appears truncated in filing, so no specific figures available.
No financial results, guidance, or business developments are disclosed in the furnished exhibit text.
Filing signed by CFO Thomas Eastling.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.